Open AccessHOW TO MINIMIZE THE BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS: LESSONS DRAWN FROM RANDOMIZED TRIALS AND NEW CLINICAL GUIDELINES
Author(s) -
О. О. Шахматова,
Е. П. Панченко
Publication year - 2018
Publication title -
aterotromboz
Language(s) - English
Resource type - Journals
eISSN - 2658-5952
pISSN - 2307-1109
DOI - 10.21518/2307-1109-2018-1-93-106
Subject(s) - medicine , antithrombotic , clopidogrel , aspirin , atrial fibrillation , conventional pci , randomized controlled trial , warfarin , fibrinolytic agent , p2y12 , clinical trial , percutaneous coronary intervention , stroke (engine) , dabigatran , cardiology , intensive care medicine , myocardial infarction , mechanical engineering , engineering